Skip to content

Precigen PGEN Change in Inventories

Change in Inventories at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
-$14M-108%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
-$26.6M-117%
Gilead Sciences logo
Gilead SciencesGILD
$52M-76.7%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$2.17M+8.9%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$4M+300%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$7.05M+121%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's change in inventories?
Precigen (PGEN) reported change in inventories of $4.88M in Q1 2026.
What is the long-term trend for Precigen's change in inventories?
Over 2 years (2021 to 2023), Precigen's change in inventories has grown at a -100.0% compound annual growth rate (CAGR), from $1.9M to $0.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.